Biopharma Leaders Unite To Stand With Science LEARN MORE Pfizer & BioNTech to Supply Singapore with Vaccine Candidate to Combat COVID-19 LEARN MORE U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine LEARN MORE Alibaba Cloud, Fintech Academy and Pfizer Partner to Accelerate Healthcare Innovations LEARN MORE LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer LEARN MORE RECENT PRESS RELEASES 20/01/2021 - Pfizer and BioNTech PuResults of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture 14/01/2021 - Pfizer’s XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults 12/01/2021 - Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative 08/01/2021 - An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission 07/01/2021 - Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy 05/01/2021 - Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference 04/01/2021 - US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency 29/12/2020 - Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY® 28/12/2020 - LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA 28/12/2020 - Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health 23/12/2020 - Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine 22/12/2020 - Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts 21/12/2020 - Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine 21/12/2020 - Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine 14/12/2020 - Pfizer and BioNTech to Supply Singapore with their BNT162b2 mRNA-based Vaccine Candidate to Combat COVID-19 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
